HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-7 treatment counteracts IFN-α therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaques.

Abstract
Interferon-α (IFN-α)-based therapy is presently the standard treatment for hepatitis C virus (HCV)-infected patients. Despite good effectiveness, this cytokine is associated with major side effects, including significant lymphopenia, that limits its use for HIV/HCV-coinfected patients. Interleukin-7 (IL-7) has recently shown therapeutic potential and safety in several clinical trials designed to demonstrate T-cell restoration in immunodeficient patients. The purpose of this study was to evaluate, in simian immunodeficiency virus-infected rhesus macaques, the relevance of IL-7 therapy as a means to overcoming IFN-α-induced lymphopenia. We showed that low-dose IFN-α treatment induced strong lymphopenia in chronically infected monkeys. In contrast, high-dose IFN-α treatment stimulated IL-7 production, leading to increased circulating T-cell counts. Moreover, IL-7 therapy more than abrogated the lymphopenic effect of low-dose IFN-α. Indeed, the association of both cytokines resulted in increased circulating T-cell counts, in particular in the naive compartments, as a consequence of central and peripheral homeostatic functions of the IL-7. Finally, reduced PD-1 expression by memory CD8(+) T cells and transient T-cell repertoire diversification were observed under IL-7 therapy. Our data strongly suggest that IL-7 immunotherapy will be of substantial benefit in the treatment of HIV/HCV coinfection and should enhance the likelihood of HCV eradication in poorly responding patients.
AuthorsRaphaëlle Parker, Jacques Dutrieux, Stéphanie Beq, Brigitte Lemercier, Sandra Rozlan, Véronique Fabre-Mersseman, Magali Rancez, Céline Gommet, Brigitte Assouline, Iann Rancé, Annick Lim, Michel Morre, Rémi Cheynier
JournalBlood (Blood) Vol. 116 Issue 25 Pg. 5589-99 (Dec 16 2010) ISSN: 1528-0020 [Electronic] United States
PMID20841508 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Interferon-alpha
  • Interleukin-7
Topics
  • Animals
  • Antiviral Agents (therapeutic use)
  • Flow Cytometry
  • Humans
  • Immunologic Memory
  • Interferon-alpha (therapeutic use)
  • Interleukin-7 (therapeutic use)
  • Lymphocyte Activation (drug effects)
  • Lymphopenia (chemically induced, drug therapy)
  • Macaca mulatta
  • Simian Acquired Immunodeficiency Syndrome (drug therapy, immunology)
  • Simian Immunodeficiency Virus (immunology)
  • T-Lymphocytes (cytology, drug effects, immunology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: